Lipidomics Department, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B. P. Hasdeu Street, 050568, Bucharest, Romania.
Cardiovascular Research Unit, Luxembourg Institute of Health, 1445, Strassen, Luxembourg.
Sci Rep. 2020 Nov 25;10(1):20549. doi: 10.1038/s41598-020-77539-4.
Dyslipidemia is a documented risk factor for cardiovascular diseases and other metabolic disorders. Therefore, the analysis of hyperlipidemia (HL)-related miRNAs is a potential approach for achieving new prognostic markers in lipid-metabolism related diseases. We aimed to analyze specific distribution of miRNAs in different tissues from HL animals. Golden Syrian hamsters were fed either regular chow (NL) or high-fat diet (HL) for 12 weeks. Microarray miRNAs profiling was performed in liver, heart and small intestine and data analyzed by R-studio software. Functional enrichment bioinformatics analysis was performed using miRWalk and DAVID tools. We observed a dysregulation of miRNAs in HL tissues evidencing a discrete distribution in the heart-liver axis and three lipid metabolism-related miRNAs were identified: hsa-miR-223-3p, hsa-miR-21-5p, and hsa-miR-146a-5p. Expression levels of these miRNAs were increased in HL livers and hearts. Functional bioinformatics analysis showed involvement of these miRNAs in the regulation of biological processes altered in HL conditions such as lipid metabolic process, fat cell differentiation, regulation of smooth muscle cells and cardiac septum development. We identified a set of miRNAs dysregulated in different tissues of HFD-induced HL hamsters. These findings motivate further studies aiming to investigate novel molecular mechanisms of lipid metabolism and atherogenic HL.
血脂异常是心血管疾病和其他代谢紊乱的已证实的危险因素。因此,分析与高脂血症(HL)相关的 miRNA 是实现与脂质代谢相关疾病新预后标志物的潜在方法。我们旨在分析 HL 动物不同组织中特定 miRNA 的分布。用普通饲料(NL)或高脂肪饮食(HL)喂养金黄地鼠 12 周。在肝脏、心脏和小肠中进行 microarray miRNAs 谱分析,并使用 R-studio 软件分析数据。使用 miRWalk 和 DAVID 工具进行功能丰富的生物信息学分析。我们观察到 HL 组织中 miRNA 的失调,证明在心脏-肝脏轴中有离散分布,并且鉴定出三种与脂质代谢相关的 miRNA:hsa-miR-223-3p、hsa-miR-21-5p 和 hsa-miR-146a-5p。这些 miRNA 在 HL 肝脏和心脏中的表达水平增加。功能生物信息学分析表明,这些 miRNA 参与了 HL 条件下改变的生物学过程的调节,如脂质代谢过程、脂肪细胞分化、平滑肌细胞调节和心脏中隔发育。我们鉴定出一组在 HFD 诱导的 HL 金黄地鼠不同组织中失调的 miRNA。这些发现促使进一步研究旨在探讨脂质代谢和致动脉粥样硬化 HL 的新分子机制。